Regulation of striatal dopamine release by metabotropic glutamate receptors

Anita Verma, Bita Moghaddam

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

In vivo microdialysis in conscious rats was used to assess the effect of metabotropic glutamate receptor stimulation on striatal dopamine release. Local application of the metabotropic glutamate agonist (±)-trans-1- aminocyclopentane-1,3-dicarboxylic acid (ACPD), via a microdialysis probe, produced a concentration-dependent response: infusion of 50 μM ACPD did not produce a significant effect on extracellular dopamine levels, while application of 100 μM or 500 μM ACPD increased dopamine release by approximately 50% or 100%, respectively. To examine the contribution of impulse flow and multisynaptic mechanisms to the ACPD-induced increase in dopamine release, 500 μM ACPD were coapplied with 2 μM tetrodotoxin (TTX). An increase in extracellular dopamine levels was observed after the application of 500 μM ACPD, despite the presence of TTX. To further study the actions of metabotropic glutamate receptor-stimulation on terminal release characteristics of dopamine, the effect of ACPD on 40 mM K+- stimulated dopamine release was investigated. It was found that application of ACPD reduces dopamine release in response to K+ stimulation. These data suggest that during basal conditions, metabotropic glutamate receptor activation facilitates striatal dopamine release, possibly through presynaptic, impulse-independent mechanisms. However, during conditions of hyperstimulation, activation of metabotropic receptors, in contrast to ionotropic receptors, reduces excess dopamine release.

Original languageEnglish (US)
Pages (from-to)220-226
Number of pages7
JournalSynapse
Volume28
Issue number3
DOIs
StatePublished - Mar 1998
Externally publishedYes

Fingerprint

Corpus Striatum
Metabotropic Glutamate Receptors
Dicarboxylic Acids
Dopamine
Microdialysis
Tetrodotoxin
Excitatory Amino Acid Agonists
Dopamine Agents

Keywords

  • ACPD
  • Excitatory amino acids
  • Microdialysis
  • Schizophrenia

ASJC Scopus subject areas

  • Neuroscience(all)
  • Physiology
  • Pharmacology

Cite this

Regulation of striatal dopamine release by metabotropic glutamate receptors. / Verma, Anita; Moghaddam, Bita.

In: Synapse, Vol. 28, No. 3, 03.1998, p. 220-226.

Research output: Contribution to journalArticle

@article{e6ee0b2973fa44269a54be9de33eeb61,
title = "Regulation of striatal dopamine release by metabotropic glutamate receptors",
abstract = "In vivo microdialysis in conscious rats was used to assess the effect of metabotropic glutamate receptor stimulation on striatal dopamine release. Local application of the metabotropic glutamate agonist (±)-trans-1- aminocyclopentane-1,3-dicarboxylic acid (ACPD), via a microdialysis probe, produced a concentration-dependent response: infusion of 50 μM ACPD did not produce a significant effect on extracellular dopamine levels, while application of 100 μM or 500 μM ACPD increased dopamine release by approximately 50{\%} or 100{\%}, respectively. To examine the contribution of impulse flow and multisynaptic mechanisms to the ACPD-induced increase in dopamine release, 500 μM ACPD were coapplied with 2 μM tetrodotoxin (TTX). An increase in extracellular dopamine levels was observed after the application of 500 μM ACPD, despite the presence of TTX. To further study the actions of metabotropic glutamate receptor-stimulation on terminal release characteristics of dopamine, the effect of ACPD on 40 mM K+- stimulated dopamine release was investigated. It was found that application of ACPD reduces dopamine release in response to K+ stimulation. These data suggest that during basal conditions, metabotropic glutamate receptor activation facilitates striatal dopamine release, possibly through presynaptic, impulse-independent mechanisms. However, during conditions of hyperstimulation, activation of metabotropic receptors, in contrast to ionotropic receptors, reduces excess dopamine release.",
keywords = "ACPD, Excitatory amino acids, Microdialysis, Schizophrenia",
author = "Anita Verma and Bita Moghaddam",
year = "1998",
month = "3",
doi = "10.1002/(SICI)1098-2396(199803)28:3<220::AID-SYN5>3.0.CO;2-C",
language = "English (US)",
volume = "28",
pages = "220--226",
journal = "Synapse",
issn = "0887-4476",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Regulation of striatal dopamine release by metabotropic glutamate receptors

AU - Verma, Anita

AU - Moghaddam, Bita

PY - 1998/3

Y1 - 1998/3

N2 - In vivo microdialysis in conscious rats was used to assess the effect of metabotropic glutamate receptor stimulation on striatal dopamine release. Local application of the metabotropic glutamate agonist (±)-trans-1- aminocyclopentane-1,3-dicarboxylic acid (ACPD), via a microdialysis probe, produced a concentration-dependent response: infusion of 50 μM ACPD did not produce a significant effect on extracellular dopamine levels, while application of 100 μM or 500 μM ACPD increased dopamine release by approximately 50% or 100%, respectively. To examine the contribution of impulse flow and multisynaptic mechanisms to the ACPD-induced increase in dopamine release, 500 μM ACPD were coapplied with 2 μM tetrodotoxin (TTX). An increase in extracellular dopamine levels was observed after the application of 500 μM ACPD, despite the presence of TTX. To further study the actions of metabotropic glutamate receptor-stimulation on terminal release characteristics of dopamine, the effect of ACPD on 40 mM K+- stimulated dopamine release was investigated. It was found that application of ACPD reduces dopamine release in response to K+ stimulation. These data suggest that during basal conditions, metabotropic glutamate receptor activation facilitates striatal dopamine release, possibly through presynaptic, impulse-independent mechanisms. However, during conditions of hyperstimulation, activation of metabotropic receptors, in contrast to ionotropic receptors, reduces excess dopamine release.

AB - In vivo microdialysis in conscious rats was used to assess the effect of metabotropic glutamate receptor stimulation on striatal dopamine release. Local application of the metabotropic glutamate agonist (±)-trans-1- aminocyclopentane-1,3-dicarboxylic acid (ACPD), via a microdialysis probe, produced a concentration-dependent response: infusion of 50 μM ACPD did not produce a significant effect on extracellular dopamine levels, while application of 100 μM or 500 μM ACPD increased dopamine release by approximately 50% or 100%, respectively. To examine the contribution of impulse flow and multisynaptic mechanisms to the ACPD-induced increase in dopamine release, 500 μM ACPD were coapplied with 2 μM tetrodotoxin (TTX). An increase in extracellular dopamine levels was observed after the application of 500 μM ACPD, despite the presence of TTX. To further study the actions of metabotropic glutamate receptor-stimulation on terminal release characteristics of dopamine, the effect of ACPD on 40 mM K+- stimulated dopamine release was investigated. It was found that application of ACPD reduces dopamine release in response to K+ stimulation. These data suggest that during basal conditions, metabotropic glutamate receptor activation facilitates striatal dopamine release, possibly through presynaptic, impulse-independent mechanisms. However, during conditions of hyperstimulation, activation of metabotropic receptors, in contrast to ionotropic receptors, reduces excess dopamine release.

KW - ACPD

KW - Excitatory amino acids

KW - Microdialysis

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=0031910849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031910849&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-2396(199803)28:3<220::AID-SYN5>3.0.CO;2-C

DO - 10.1002/(SICI)1098-2396(199803)28:3<220::AID-SYN5>3.0.CO;2-C

M3 - Article

C2 - 9488507

AN - SCOPUS:0031910849

VL - 28

SP - 220

EP - 226

JO - Synapse

JF - Synapse

SN - 0887-4476

IS - 3

ER -